Bi-Specific Antibodies Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Bi-Specific Antibodies Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bi-Specific Antibodies Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bi-Specific Antibodies Therapy Overall Market Size
2.1 Global Bi-Specific Antibodies Therapy Market Size: 2022 VS 2029
2.2 Global Bi-Specific Antibodies Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bi-Specific Antibodies Therapy Players in Global Market
3.2 Top Global Bi-Specific Antibodies Therapy Companies Ranked by Revenue
3.3 Global Bi-Specific Antibodies Therapy Revenue by Companies
3.4 Top 3 and Top 5 Bi-Specific Antibodies Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bi-Specific Antibodies Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Players in Global Market
3.6.1 List of Global Tier 1 Bi-Specific Antibodies Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bi-Specific Antibodies Therapy Market Size Markets, 2022 & 2029
4.1.2 Fragment-Based Antibodies
4.1.3 IgG-Based Antibodies
4.2 By Type - Global Bi-Specific Antibodies Therapy Revenue & Forecasts
4.2.1 By Type - Global Bi-Specific Antibodies Therapy Revenue, 2018-2023
4.2.2 By Type - Global Bi-Specific Antibodies Therapy Revenue, 2024-2029
4.2.3 By Type - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bi-Specific Antibodies Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Haemophilia
5.1.4 Other Non-Cancer Diseases
5.2 By Application - Global Bi-Specific Antibodies Therapy Revenue & Forecasts
5.2.1 By Application - Global Bi-Specific Antibodies Therapy Revenue, 2018-2023
5.2.2 By Application - Global Bi-Specific Antibodies Therapy Revenue, 2024-2029
5.2.3 By Application - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Bi-Specific Antibodies Therapy Market Size, 2022 & 2029
6.2 By Region - Global Bi-Specific Antibodies Therapy Revenue & Forecasts
6.2.1 By Region - Global Bi-Specific Antibodies Therapy Revenue, 2018-2023
6.2.2 By Region - Global Bi-Specific Antibodies Therapy Revenue, 2024-2029
6.2.3 By Region - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Bi-Specific Antibodies Therapy Revenue, 2018-2029
6.3.2 US Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.3.3 Canada Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.3.4 Mexico Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Bi-Specific Antibodies Therapy Revenue, 2018-2029
6.4.2 Germany Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4.3 France Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4.4 U.K. Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4.5 Italy Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4.6 Russia Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.4.8 Benelux Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Bi-Specific Antibodies Therapy Revenue, 2018-2029
6.5.2 China Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.5.3 Japan Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.5.4 South Korea Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.5.6 India Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Bi-Specific Antibodies Therapy Revenue, 2018-2029
6.6.2 Brazil Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.6.3 Argentina Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bi-Specific Antibodies Therapy Revenue, 2018-2029
6.7.2 Turkey Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.7.3 Israel Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Bi-Specific Antibodies Therapy Market Size, 2018-2029
6.7.5 UAE Bi-Specific Antibodies Therapy Market Size, 2018-2029
7 Bi-Specific Antibodies Therapy Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Bi-Specific Antibodies Therapy Major Product Offerings
7.1.4 Roche Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Bi-Specific Antibodies Therapy Major Product Offerings
7.2.4 Amgen Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Bi-Specific Antibodies Therapy Major Product Offerings
7.3.4 Sanofi Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Bi-Specific Antibodies Therapy Major Product Offerings
7.4.4 Pfizer Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Major Product Offerings
7.5.4 Johnson & Johnson Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Bi-Specific Antibodies Therapy Major Product Offerings
7.6.4 AstraZeneca Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Bi-Specific Antibodies Therapy Major Product Offerings
7.7.4 AbbVie Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Lindis Biotech
7.8.1 Lindis Biotech Company Summary
7.8.2 Lindis Biotech Business Overview
7.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Major Product Offerings
7.8.4 Lindis Biotech Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.8.5 Lindis Biotech Key News & Latest Developments
7.9 MacroGenics, Inc
7.9.1 MacroGenics, Inc Company Summary
7.9.2 MacroGenics, Inc Business Overview
7.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Major Product Offerings
7.9.4 MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.9.5 MacroGenics, Inc Key News & Latest Developments
7.10 Genmab
7.10.1 Genmab Company Summary
7.10.2 Genmab Business Overview
7.10.3 Genmab Bi-Specific Antibodies Therapy Major Product Offerings
7.10.4 Genmab Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.10.5 Genmab Key News & Latest Developments
7.11 Alphamab Co. Ltd
7.11.1 Alphamab Co. Ltd Company Summary
7.11.2 Alphamab Co. Ltd Business Overview
7.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Major Product Offerings
7.11.4 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.11.5 Alphamab Co. Ltd Key News & Latest Developments
7.12 Akeso, Inc.
7.12.1 Akeso, Inc. Company Summary
7.12.2 Akeso, Inc. Business Overview
7.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Major Product Offerings
7.12.4 Akeso, Inc. Bi-Specific Antibodies Therapy Revenue in Global Market (2018-2023)
7.12.5 Akeso, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Bi-Specific Antibodies Therapy Market Opportunities & Trends in Global Market
Table 2. Bi-Specific Antibodies Therapy Market Drivers in Global Market
Table 3. Bi-Specific Antibodies Therapy Market Restraints in Global Market
Table 4. Key Players of Bi-Specific Antibodies Therapy in Global Market
Table 5. Top Bi-Specific Antibodies Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bi-Specific Antibodies Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bi-Specific Antibodies Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bi-Specific Antibodies Therapy Product Type
Table 9. List of Global Tier 1 Bi-Specific Antibodies Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Bi-Specific Antibodies Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bi-Specific Antibodies Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Bi-Specific Antibodies Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bi-Specific Antibodies Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Bi-Specific Antibodies Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bi-Specific Antibodies Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Bi-Specific Antibodies Therapy Product Offerings
Table 32. Roche Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Bi-Specific Antibodies Therapy Product Offerings
Table 36. Amgen Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Bi-Specific Antibodies Therapy Product Offerings
Table 40. Sanofi Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Bi-Specific Antibodies Therapy Product Offerings
Table 44. Pfizer Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Bi-Specific Antibodies Therapy Product Offerings
Table 48. Johnson & Johnson Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Bi-Specific Antibodies Therapy Product Offerings
Table 52. AstraZeneca Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Bi-Specific Antibodies Therapy Product Offerings
Table 56. AbbVie Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Lindis Biotech Company Summary
Table 59. Lindis Biotech Bi-Specific Antibodies Therapy Product Offerings
Table 60. Lindis Biotech Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Lindis Biotech Key News & Latest Developments
Table 62. MacroGenics, Inc Company Summary
Table 63. MacroGenics, Inc Bi-Specific Antibodies Therapy Product Offerings
Table 64. MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. MacroGenics, Inc Key News & Latest Developments
Table 66. Genmab Company Summary
Table 67. Genmab Bi-Specific Antibodies Therapy Product Offerings
Table 68. Genmab Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Genmab Key News & Latest Developments
Table 70. Alphamab Co. Ltd Company Summary
Table 71. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Product Offerings
Table 72. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Alphamab Co. Ltd Key News & Latest Developments
Table 74. Akeso, Inc. Company Summary
Table 75. Akeso, Inc. Bi-Specific Antibodies Therapy Product Offerings
Table 76. Akeso, Inc. Bi-Specific Antibodies Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Akeso, Inc. Key News & Latest Developments
List of Figures
Figure 1. Bi-Specific Antibodies Therapy Segment by Type in 2022
Figure 2. Bi-Specific Antibodies Therapy Segment by Application in 2022
Figure 3. Global Bi-Specific Antibodies Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bi-Specific Antibodies Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bi-Specific Antibodies Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bi-Specific Antibodies Therapy Revenue in 2022
Figure 8. By Type - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 16. US Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 28. China Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Bi-Specific Antibodies Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lindis Biotech Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Genmab Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Akeso, Inc. Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
